Antielastasic activity of antistressants in bone tissue of rats after stress
DOI:
https://doi.org/10.12775/JEHS.2026.89.70805Keywords
elastase, bone tissue, stress, anti-stress agentsAbstract
Background. Stress causes the development of post-stress pathological reactions, which culminate in dysmetabolic disorders, against the background of which most diseases of humans and animals develop. Bone tissue has been found to be one of the most sensitive organs and tissues to the effects of dysmetabolic syndrome.
Aim. Study of the effect of stress on the activity of the proteolytic enzyme elastase in bone tissue and determination of the possibility of preventing elastase activation using anti-stress agents.
Methods. Stress was induced in rats by holding the animals at −20 °C for 30 minutes and elastase activity was investigated on the 4th day after stress. Antioxidant preparations EkSoVit, Quercetin and ascorbic acid were used as anti-stressors, which were administered into the oral cavity 3 days before stress and 3 days after stress in the form of an oral gel in doses (mg/kg): EkSoVit 0.43 and 1.07, Quercetin 0.128 and 0.257 and ascorbic acid 0.257.
Results. In rats without stress, the elastase activity in the femur was (μk-kat/kg) 6.66; in rats after stress 9.61; in rats with stress that received EkSoVit, 8.16 and 6.90; in rats with stress that received quercetin, 7.20 and 5.60; in rats with stress that received ascorbic acid, 7.20. The antielastase activity in vivo was: EkSoVit – 49.15 and 126.05; quercetin – 112.10 and 135.93 and ascorbic acid – 81.63. The antielastase efficacy of antistressants was after conversion of antielastase activity to a dose of 1 g/kg: for EkSoVit 114.3 and 117.8; for quercetin 875.8 and 528.9; for ascorbic acid 317.8.
Conclusion. After stress, the activity of the proteolytic enzyme elastase increases in bone tissue. The use of anti-stress agents with antioxidant action significantly prevents the activation of elastase. The most effective anti-elastase drug was quercetin (vitamin P).
References
1. Goldstein DS, Kopin IJ. Evolution of concepts of stress. Stress. 2007;10(2):109-120. doi: 10.1080/10253890701288935
2. Levitsky AP, Malinovskii VО, Yuzkiv YaS, Pavlenko KV, Selivanskaya IО, Lapinska AP. Four stages after stress reactions. Journal of Education, Health and Sport. 2025;86:67246. https://apcz.umk.pl/JEHS/article/view/67246
3. Reddy VP. Oxidative Stress in Health and Disease. Biomedicines. 2023;11(11): 2925. doi: 10.3390/biomedicines11112925
4. Levitsky AP. Disbiotic syndrome: etiology, pathogenesis, clinic, prevention and treatment. Dentistry Bulletin. 2019;10(special issue):14-20. (in Russian)
5. Mishhenko OJa, Halejeva OL, Ryzhenko IM [and others]. Possibilities of pharmacological correction of stress-induced immune system disorders using herbal medicines (literature review). Phytotherapy. Journal. 2020;2:4-10. Doi:10.33617/2522-9680-2020-2-4. (in Ukrainian)
6. Lambert GP. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J Anim Sci. 2009;87(14):E101-108. doi: 10.2527/jas.2008-1339.
7. Levitsky AP, Stepan VT, Pustovoit PI. Comparative nephrotoxic effect on rats of different pathogens. Journal of Education, Health and Sport. 2020;10(10):212-218. DOI http://dx.doi.org/10.12775/JEHS.2020.10.10.019.
8. Ndrepepa G. Myeloperoxidase − A bridge linking inflammation and oxidative stress with cardiovascular disease. Clin Chim Acta. 2019;493:36-51. doi: 10.1016/j.cca.2019.02.022.
9. Gorchakova NO, Shumejko OV, Klimenko OV [and others]. Anti-stress and antioxidant properties of herbal medicines: Proceedings of the scientific congress “NATO: comprehensive complementary and alternative interventions for persons injured during military events, military personnel, their families, during the period of physical and medical rehabilitation”, June 13-14, 2024, Kyiv. P. 141-142. (in Ukrainian)
10. Synovec AS, Levitsky AP. Proteolytic enzyme inhibitors in medicine. Kyiv: Zdorov’ja, 1979:80. (in Russian)
11. João JMLG, Barbosa JAS, Da Silva LLS. Plant protease inhibitors compared to corticosteroids in mice with Asthma-COPD. European Respiratory Journal 2020;56(64):3306. DOI: https://doi.org/10.1183/13993003.congress-2020.3306
12. Levitsky AP, Makarenko OA, Levchenko OM [and others]. Bioflavonoid hepatoprotectors. Odessa: KP OGT, 2014:86. (in Russian)
13. Levitsky AP, Pavlenko KV, Selivanska IО, Lapinska AP. Enzymatic method for determining in vivo the mineralizing efficiency of osteoprotective drugs. Journal of Education, Health and Sport. 2026;87:68087. https://apcz.umk.pl/JEHS/article/view/68087
14. Levitsky AP, Stefanov AV. The methods of the determination of the activity of elastase and its inhibitors: method guidelines. Kiev: GFK, 2002:15. (in Russian)
15. Levitsky AP, Makarenko OA, Denga OV [and others]. The experimental methods of the study of osteogenesis stimulators: method guidelines. Kiev: GFK, 2005:50. (in Russian)
16. Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29(11):2520-2526. https://doi.org/10.1002/jbmr.2269.
17. Sacco SM, Horcajada MN, Offord E. Phytonutrients for bone health during ageing. Br J Clin Pharmacol. 2013;75(3):697-707. doi: 10.1111/bcp.12033.
18. Bacchetti T, Turco I, Urbano A, Morresi C, Ferretti G. Relationship of fruit and vegetable intake to dietary antioxidant capacity and markers of oxidative stress: A sex-related study. Nutrition. 2019. 61. Р. 164-172. doi: 10.1016/j.nut.2018.10.034.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 K. Pavlenko
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 2
Number of citations: 0
